T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant

Clinical trial NCT01621477 · TERMINATED

Trial details

NCT number: NCT01621477
Sponsor: St. Jude Children's Research Hospital
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia Acute Myelocytic Leukemia Chronic Myelocytic Leukemia Juvenile Myelomonocytic Leukemia Myelodysplastic Syndrome Hodgkin or Non-Hodgkin Lymphoma Sarcoma, Myeloid

Start date: 2012-08-01
Primary completion: 2015-12-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.